There were 60 press releases posted in the last 24 hours and 398,208 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image